03 Profile
Vital Signsby Bridgehead
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Children's health
Haydar Frangoul: no photograph is held, so the clinician plate is shown instead.
Clinician
Haydar Frangoul
medical director of HCA Healthcare's Sarah Cannon Transplant and Cellular Therapy Programme at TriStar Centennial Children's Hospital
July 2026Aug 2026Sept 2026Oct 2026Nov 2026to date
2
Quoted in the press, across 2 topics since 2 Jul 2026
02 Quoted on · 2 of 29 topics
Haydar Frangoul: key facts
- Kind of voice
- Clinician
- Role
- medical director of HCA Healthcare's Sarah Cannon Transplant and Cellular Therapy Programme at TriStar Centennial Children's Hospital
- Quoted on
- Children's health, Rare diseases
- Press coverage
- Quoted in the press
- Most recently quoted
- 2 Jul 2026
04 The signal · where Haydar Frangoul sits on rare diseases
Quoted
Quoted in the press on rare diseases.
Placed by press coverage on this topic only, not across all topics.
- Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)Leading
- Dr Harrison CarterAcademicDirector of Screening at NHS EnglandLeading
- Dr Rich ScottSector leaderChief Executive Officer of Genomics EnglandLeading
- Robert Harmon, PhDAcademicresearch assistant professor of Pathology
- Alex HorsleyAcademicProfessor, University of Manchester
- Haydar FrangoulClinicianmedical director of HCA Healthcare's Sarah Cannon Transplant and Cellular Therapy Programme at TriStar Centennial Children's Hospital
- Dr Anil JoshiClinicianconsultant ENT and facial plastic surgeon
- Professor Rob GallowayClinicianConsultant in Emergency Medicine; Founder and trustee, Rare People – The Research Charity; Honorary Clinical Professor, Brighton and Sussex Medical School, University Hospitals Sussex NHS Foundation Trust / Rare People – The Research Charity
Showing the leading voices and those placed around Haydar Frangoul · See every voice on the topic →
05 On the record · press
What Haydar Frangoul has said
By outlet · bar length shows relative volume
- pharmaphorum.com
Where Haydar Frangoul has been quoted
- Vertex gets paediatric FDA okay for Casgevy gene therapypharmaphorum.com · 2 Jul 2026
- Vertex gets paediatric FDA okay for Casgevy gene therapy | pharmaphorumpharmaphorum.com · 2 Jul 2026
How we found the articles that name Haydar Frangoul: we searched news for these terms, by topic. Terms for 2 topics
Children's health
- children's health
- paediatric
- child health
- children's hospital
- infant mortality
Also searched with “children's health” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Children's health
Rare diseases
- rare disease
- rare conditions
- orphan drugs
- genetic disorder
- cystic fibrosis
- motor neurone disease
- muscular dystrophy
- Huntington
Also searched with “rare disease” in each of 8 national papers. Every term for Rare diseases
Verbatim
“Earlier access to the transformative potential of this therapy will allow clinicians and families to consider treatment before years of cumulative damage from these life-shortening diseases take hold.”
“Earlier access to the transformative potential of this therapy will allow clinicians and families to consider treatment before years of cumulative damage from these life-shortening diseases take hold”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.